Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...

Rapid fat loss from GLP-1 medications like Ozempic can lead to 'Ozempic face', characterized by hollow cheeks and sagging skin. Drinking water, eating a protein-rich diet, and practicing face yoga ...

Experts have sounded the alarm about blockbuster weight loss drugs like Ozempic leaving users blind. Several studies have linked the shots to conditions that cause inflammation and block blood ...

Ozempic has skyrocketed in popularity as both a diabetes medication and a weight loss aid, but a growing number of patients are reporting an unexpected and puzzling side effect. Some users have ...

Ozempic (semaglutide) is a subcutaneous injection used in people with type 2 diabetes. It may cause mild side effects, such as abdominal pain, or more serious side effects, such as diabetic ...

Are you a print subscriber? Activate your account. By Tim Nudd - 14 min 58 sec ago 2 hours 35 min ago By Parker Herren - 2 hours 48 min ago By Brian Bonilla - 2 hours 48 min ago By Jean-Paul ...

He also published one of the first case series that found semaglutide, the active ingredient in Ozempic, to effectively reduce alcohol consumption among six people with addiction. (The drug ...

Amy Schumer is getting candid about her unpleasant experience on the weight loss drug Ozempic. The comedian and actress, 43, ...

Do a quick Google search for berberine and you will come across a handful of interesting headlines referring to it as “nature’s Ozempic.” And considering the rising popularity of Ozempic and ...

In the UK, the Medicines and Healthcare products Regulatory Agency (MHRA) reported seizing 369 potentially fake Ozempic pens between January and October in 2023, marking the first identification ...

Thousands of tremors, sometimes every few minutes, have shaken Santorini, Greece. More than 13,000 of its 15,500 inhabitants have left. By Niki Kitsantonis Reporting from Athens February is a slow ...

Ozempic/Wegovy is the first drug on HHS's 2025 list of Medicare price negotiations. As the leaders of the pharmaceutical industry boarded their planes to come home from the JP Morgan Healthcare ...